Empozin-M Tablets 12.5mg/1000mg

Used For:

Empozin-M 12.5mg/1000mg Tablet is a combination of two active ingredients: empagliflozin (12.5mg) and metformin (1000mg). It is prescribed to manage type 2 diabetes by helping control blood sugar levels.

• Empagliflozin works by increasing glucose excretion through urine, helping to lower blood sugar.
• Metformin decreases glucose production in the liver and improves insulin sensitivity.

This combination helps improve glycemic control in patients who are not achieving sufficient results with diet, exercise, or individual medications alone, and it may also reduce the risk of cardiovascular complications in adults with type 2 diabetes and heart disease.

Side Effects:

Common side effects may include:

• Nausea, vomiting, or diarrhea
• Stomach upset or bloating
• Increased urination
• Urinary tract infections
• Genital yeast infections

Serious but rare side effects:

• Lactic acidosis (related to metformin, a rare but serious metabolic condition)
• Ketoacidosis (dangerous buildup of acid in the blood)
• Kidney issues
• Dehydration
• Low blood sugar (especially when combined with other diabetes medications)

Precautions:

• Not recommended for individuals with type 1 diabetes or those prone to diabetic ketoacidosis.
• Consult your doctor if you have kidney or liver problems before starting this medication, as it can worsen these conditions.
• Be aware of the symptoms of lactic acidosis (e.g., muscle pain, difficulty breathing, severe tiredness) and seek medical attention if they occur.
• Stay hydrated, as this medication can cause dehydration due to increased urination.
• Avoid use if you are pregnant or breastfeeding unless prescribed by your healthcare provider.